Pharmaceuticals Divestitures in 2019
-
December 13, 2019
- Buyer
- The Riverside Company
- Target
- HealthTech BioActives S.L. (HTBA)
- Seller
- Ferrer
- Industry
- Pharmaceuticals
- Location
- Catalonia, Spain
- Type
- Divestiture
The Riverside Company has acquired HealthTech BioActives S.L. (HTBA), a Spanish manufacturer of APIs, excipients, natural flavors and vitamin B12 derivatives, in a carve-out from Ferrer. Riverside will work with HTBA’s ~140 employees and its manufacturing sites in Beniel (Murcia) and Barcelona to strengthen commercial capabilities, accelerate new product development and expand global sales.
-
December 12, 2019
- Buyer
- STADA Group
- Target
- Biopharma (pharmaceutical prescription and consumer health business)
- Seller
- Biopharma
- Industry
- Pharmaceuticals
- Location
- Kyiv Oblast, Ukraine
- Type
- Divestiture
The STADA Group agreed to acquire the pharmaceutical prescription and consumer health business of Ukrainian producer Biopharma, including GMP-certified production facilities in Bila Tserkva. The deal integrates Biopharma's pharma operations into STADA's European organization, expands STADA's local production footprint in Ukraine and is subject to Ukrainian merger control; Biopharma's shareholders will retain the company's plasma business.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.